This is a preview of subscription content, log in via an institution to check access.
References
Almawi W. Y., Tamim H. and Azar S. T. 1999 T helper type 1 and 2 cytokines mediate the onset and progression of type I (insulin-dependent) diabetes. J. Clin. Endocrinol. Metab. 84, 1497–1502.
American Diabetes Association 2003 Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 26,suppl. 1, S5–S20.
Atkinson M. A. and MacLaren N. K. 1994 The pathogenesis of insulin-dependent diabetes mellitus. New Engl. J. Med. 331, 1428–1436.
D’Alfonso S., Rampi M., Bocchio D., Colombo G., Scorza-Smeraldi R. and Momigliano-Richardi P. 2000 Systemic lupus erythematosus candidate genes in the Italian population: evidence for a significant association with interleukin-10. Arthritis Rheum. 43, 120–128. Erratum in: 2000 Arthritis Rheum. 43, 1442.
Eisenbarth G. S. 2005 Type 1 diabetes mellitus. In Joslin’s diabetes mellitus (ed. C. R. Kahn, G. C. Weir, G. L. King, A. M. Jacobson, A. C. Moses and R. J. Smith), pp. 399–424. Joslin Diabetes Center, Boston.
Eskdale J., Gallagher G., Verweij C. L., Keijsers V., Westendorp R. G. and Huizinga T. W. 1998 Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc. Natl. Acad. Sci. USA 95, 9465–9470.
Excoffier L., Laval G. and Schneider S. 2005 Arlequin ver. 3.0: an integrated software package for population genetics data analysis. Evol. Bioinform. Online 1, 47–50.
Expert committee on the diagnosis and classification of diabetes mellitus 2003 Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 26,suppl. 1, S5–S20.
Ide A., Kawasaki E., Abiru N., Sun F., Takahashi R., Kuwahara H. et al. 2002 Genetic association between interleukin-10 gene promoter region polymorphisms and type 1 diabetes age-at-onset. Hum. Immunol. 63, 690–695.
Keen L. J. 2002 The extent and analysis of cytokine and cytokine receptor gene polymorphism. Transpl. Immunol. 10, 143–146.
Lee M. S., Wogensen L., Shizuru J., Oldstone M. B. and Sarvetnick N. 1994 Pancreatic islet production of murine interleukin-10 does not inhibit immune-mediated tissue destruction. J. Clin. Invest. 93, 1332–1338.
Lee M. S., Mueller R., Wicker L. S., Peterson L. B. and Sarvetnick N. 1996 IL-10 is necessary and sufficient for autoimmune diabetes in conjunction with NOD MHC homozygosity. J. Exp. Med. 183, 2663–2668.
Ma S. L., Tang N. L., Lam L. C. and Chiu H. F. 2005 The association between promoter polymorphism of the interleukin-10 gene and Alzheimer’s disease. Neurobiol. Aging 26, 1005–1010.
Mok C. C., Lanchbury J. S., Chan D. W. and Lau C. S. 1998 Interleukin-10 promoter polymorphisms in southern Chinese patients with systemic lupus erythematosus. Arthritis Rheum. 41, 1090–1095.
Moraes M. O., Santos A. R., Schonkeren J. J., Vanderborght P. R., Ottenhoff T. H., Moraes M. E. et al. 2003 Interleukin-10 promoter haplotypes are differently distributed in the Brazilian versus the Dutch population. Immunogenetics 54, 896–899.
Pakala S.V., Kurrer M. O. and Katz J. D. 1997 T helper 2 (Th2) cells induce acute pancreatitis and diabetes in immune-compromised nonobese diabetic (NOD) mice. J. Exp. Med. 186, 299–306.
Pennline K. J., Roque-Gaffney E. and Monahan M. 1994 Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. Clin. Immunol. Immunopathol. 71, 169–175.
Pyo C. W., Hur S. S., Kim Y. K., Choi H. B., Hong Y. S., Kim D. W. et al. 2003 Polymorphisms of IL-1B, IL-1RN, IL-2, IL-4, IL-6, IL-10, and IFN-gamma genes in the Korean population. Hum. Immunol. 64, 979–989.
Rapoport M. J., Jaramillo A., Zipris D., Lazarus A. H., Serreze D. V., Leiter E. H. et al. 1993 Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J. Exp. Med. 178, 87–99.
Reynier F., Cazalis M. A., Lecoq A., Paye M., Rosa A., Durand A. et al. 2006 Lack of association of IL-10 promoter gene variants with type 1 diabetes in a French population. Hum. Immunol. 67, 311–317.
Sole X., Guino E., Valls J., Iniesta R. and Moreno V. 2006 SNPStats: a web tool for the analysis of association studies. Bioinformatics 22, 1928–1929.
Tegoshi H., Hasegawa G., Obayashi H., Nakano K., Kitagawa Y., Fukui M. et al. 2002 Polymorphisms of interferon-gamma gene CA-repeat and interleukin-10 promoter region (−592A/C) in Japanese type I diabetes. Hum. Immunol. 63, 121–128.
Turner D. M., Williams D. M., Sankaran D., Lazarus M., Sinnott P. J. and Hutchinson I. V. 1997 An investigation of polymorphism in the interleukin-10 gene promoter. Eur. J. Immunogenet. 24, 1–8.
Urcelay E., Santiago J. L., de la Calle H., Martinez A., Figueredo A., Fernandez-Arquero M. et al. 2004 Interleukin-10 polymorphisms in Spanish type 1 diabetes patients. Genes. Immun. 5, 306–309.
Westendorp R. G., Langermans J. A., Huizinga T. W., Elouali A. H., Verweij C. L., Boomsma D. I. et al. 1997 Genetic influence on cytokine production and fatal meningococcal disease. Lancet 340, 170–173. Erratum in: 1997 Lancet 349, 656.
Yilmaz V., Yentur S. P. and Saruhan-Direskeneli G. 2005 IL-12 and IL-10 polymorphisms and their effects on cytokine production. Cytokine 30, 188–194.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mohebbatikaljahi, H., Menevse, S., Yetkin, I. et al. Study of interleukin-10 promoter region polymorphisms (−1082A/G, −819T/C and −592A/C) in type 1 diabetes mellitus in Turkish population. J Genet 88, 245–248 (2009). https://doi.org/10.1007/s12041-009-0034-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12041-009-0034-x